Positive Research

Individualized homeopathie treatment in women with recurrent cystitis: A retrospective case series

Authors

Katharina Gaertner

Journal

Homeopathy 2020; 109(01): A1-A28 DOI: 10.1055/s-0040-1702108

Abstract

Background
Approximately 13% of women develop recurrent urinary tract infections (rUTI) in their lifetime. Most clinicians are faced with repeated and long-term administration of broad-spectrum antimicrobial agents. This leads, however, to increased presence of drug-resistant bacteria and the disruption of normal levels of intestinal and vaginal flora and might lead to persistent infections and/or damage of the urinary tract. A new strategy is therefore warranted.

Methods: 

Design
Case series of all patients treated with individualised homeopathy (iHOM) for rUTI at the Institute of Complementary Medicine, IKOM, at the University of Bern, Switzerland.

Subjects
Four females, aged 30–79.

Observation time
November 2013 to August 2018.

Analysis
Frequency of UTI and of antibiotic (AB) treatment were documented in the patients’ files. Additionally, treatment outcomes were assessed retrospectively in a validated questionnaire on Impact on Daily Living (ORIDL).

Results
The frequency of UTI and the need for AB reduced from at least monthly to less than 3 times a year. Three of the four women had no cystitis and related intake of AB for more than 2 years. In two of these patients, a relapse of symptoms could be treated efficiently with a repetition of the same homeopathic remedy. The subjective outcome assessments of all patients was reported positive. Three patients appraised major improvement for the main complaint.

Discussion
The treatment options for rUTI are limited and not always successful. Within this case series a new approach, iHOM, results in a positive outcome, both objectively (by reducing the frequency of UTI and the amount of AB courses) and subjectively as per patients’ assessments.

Conclusion
The evolution of the disease in the analysed patients suggests that iHOM might be a reasonable approach for the treatment of rUTI. It should be further investigated with prospective open-label and controlled studies.

Keywords
Urinary tract infections, antibiotic resistance

External URL

https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0040-1702108